Abstract
Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the bladder is a rare disease, and the most effective therapeutic procedure remains unknown. We report a case of primary MALT lymphoma of the bladder regressed after rituximab in combination with CHOP chemotherapy (R-CHOP). The patient, a 84-year-old woman, presented with general fatigue and loss of weight. Computed tomography (CT) showed a solitary mass at the bladder. Histological diagnosis of the tissue obtained by transurethral biopsy was extranodal marginal zone B cell lymphoma of MALT. The patient was in complete remission after only one cycle of R-CHOP. This is the fourteenth case of MALT lymphoma of the bladder in Japan.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged, 80 and over
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Humans
-
Lymphoma, B-Cell, Marginal Zone / drug therapy*
-
Prednisolone / administration & dosage
-
Remission Induction
-
Rituximab
-
Urinary Bladder Neoplasms / drug therapy*
-
Vincristine / administration & dosage
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisolone